Impact of radiotherapy parameters on outcome for patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study-Reference-Cited by-同舟云学术

Impact of radiotherapy parameters on outcome for patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study

Published:2009-07 Issue:1 Volume:92 Page:83-88
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Taylor Roger E.,Donachie Paul H.J.,Weston Claire L.,Robinson Kathryn J.,Lucraft Helen,Saran Frank,Ellison David W.,Ironside James,Walker David A.,Pizer Barry L.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference24 articles.

1. The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumours;Rorke;J Neuropathol Exp Neurol,1983

2. Supratentorial primitive neuroectodermal tumours in children;Dirks;J Neurooncol,1996

3. Preradiation chemotherapy of children and young adults with malignant brain tumours: results of the German pilot trial HIT’88./’89;Kuhl;Klin Pediatr,1998

4. Role of RT in the treatment of supratentorial primitive neuroectodermal tumours in childhood: results of the prospective German brain tumour trials HIT 88/89 and 91;Timmermann;J Clin Oncol,2002

5. Adjuvant chemotherapy for medulloblastoma: the first multicentre controlled trial of the International Society of Paediatric Oncology (SIOP);Tait;Eur J Cancer,1990

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848;International Journal of Radiation Oncology*Biology*Physics;2024-01

2. Quality improvements in radiation oncology clinical trials;Frontiers in Oncology;2023-01-26

3. MiR-1253 Potentiates Cisplatin Response in Pediatric Group 3 Medulloblastoma by Regulating Ferroptosis;2022-01-25

4. Quality assurance in radiation oncology;Pediatric Blood & Cancer;2021-04-05

5. Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma;Strahlentherapie und Onkologie;2020-11-23